Sandeep Gurbuxani

Associate Professor

University of Chicago

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sandeep Gurbuxani is an Associate Professor at the University of Chicago, USA. His research areas encompass the diagnosis and treatment of acute myeloid leukemia (AML), with a focus on leukemic stem cell biology and malignant progression of preleukemic disorders. Recent publications include studies on therapeutic implications of NPM1 mutations and the impact of cytokine signaling on myeloproliferative neoplasms.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Megan McNerney

University of Chicago

UNITED STATES

View details

Johanna Melo-Cardenas

Assistant Professor

Northwestern University

UNITED STATES

View details

Amir Behdad

UNITED STATES

View details

Wendy Stock

University of Chicago

UNITED STATES

View details

Stephen Kron

Professor

University of Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sandeep Gurbuxani

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Diagnosis and treatment of AML in the context of WHO and ICC 2022 classifications: Divergent nomenclature converges on common therapies

PHF6 suppresses self-renewal of leukemic stem cells in AML

Malignant progression of preleukemic disorders

SETBP1 sets the stage

Gata1s mutant mice display persistent defects in the erythroid lineage

EBV-positive inflammatory FDC/FRC tumor: no longer pseudo or sarcoma!

IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms

Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents

Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome–Negative B-Cell Acute Lymphoblastic Leukemia

NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring

Therapy‐related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype

Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms

bcr3 PML-RARA: short fusion, small blasts!

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

Collaborators (5)

Megan McNerney

Johanna Melo-Cardenas

Amir Behdad

Wendy Stock

Stephen Kron

Make your next move.